Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
2026
Earnings, Q3 FY2026
Q3 profitability and cash flow improved, while organic sales fell and Division North weakened.
Earnings, Q2 FY2026
Own brands drove margin and EBIT gains, with leverage at 1.0x and Risenta integration underway.
Earnings, Q1 FY2026
Gross and EBIT margins rose despite lower sales, with leverage at a historic low.
2025
Earnings, Q4 FY2025
Annual
Organic growth, margin gains, and strong cash flow highlight a robust Q4 performance.
ABGSC Investor Days
Margin improvement and restructuring drive profitability, with organic brands fueling growth.
Earnings, Q3 FY2025
EBIT margin rose to 5% in Q3, driven by organic brand growth and cost control.
Earnings, Q2 FY2025
Organic brands returned to growth, but Q2 sales and margins declined amid operational challenges.
Earnings, Q1 FY2025
Organic growth, improved cash flow, and CEO transition mark a stable but evolving quarter.
2024
Earnings, Q4 FY2024
Annual
Profitability and margins up, leverage down, with focus on organic growth and efficiency in 2025.
ABGSC Investor Days
Margin gains and growth are driven by portfolio efficiency, brand focus, and market recovery.